Motley Fool Asset Management LLC cut its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 5.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 101,475 shares of the company’s stock after selling 5,848 shares during the period. Motley Fool Asset Management LLC owned approximately 0.12% of HealthEquity worth $9,296,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently made changes to their positions in HQY. Sivia Capital Partners LLC bought a new stake in shares of HealthEquity during the second quarter worth about $306,000. Arrowstreet Capital Limited Partnership bought a new stake in shares of HealthEquity during the second quarter worth about $4,747,000. Marshall Wace LLP bought a new stake in shares of HealthEquity during the second quarter worth about $5,483,000. Amundi increased its position in shares of HealthEquity by 9.3% during the second quarter. Amundi now owns 30,203 shares of the company’s stock worth $3,059,000 after acquiring an additional 2,574 shares in the last quarter. Finally, Jump Financial LLC bought a new stake in shares of HealthEquity during the second quarter worth about $449,000. 99.55% of the stock is owned by institutional investors.
HealthEquity Stock Up 1.6%
HealthEquity stock opened at $89.23 on Wednesday. HealthEquity, Inc. has a fifty-two week low of $72.76 and a fifty-two week high of $111.44. The stock has a market cap of $7.46 billion, a PE ratio of 33.42, a price-to-earnings-growth ratio of 1.48 and a beta of 0.21. The firm’s 50-day simple moving average is $84.27 and its 200 day simple moving average is $86.03. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on HQY shares. Wells Fargo & Company set a $111.00 target price on shares of HealthEquity in a research report on Monday, June 1st. BTIG Research cut their price target on shares of HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a report on Tuesday, February 17th. Citigroup restated a “market outperform” rating on shares of HealthEquity in a report on Monday, June 1st. Wall Street Zen upgraded shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday. Finally, Barrington Research restated an “outperform” rating and set a $110.00 price target on shares of HealthEquity in a report on Friday, May 22nd. One research analyst has rated the stock with a Strong Buy rating, eleven have issued a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $110.57.
Get Our Latest Research Report on HealthEquity
Insider Buying and Selling at HealthEquity
In other HealthEquity news, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the transaction, the executive vice president directly owned 59,113 shares in the company, valued at $5,615,735. The trade was a 5.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Delano Ladd sold 7,500 shares of the business’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $675,000.00. Following the completion of the transaction, the executive vice president owned 91,141 shares in the company, valued at approximately $8,202,690. The trade was a 7.60% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 13,081 shares of company stock worth $1,193,000 over the last three months. 1.60% of the stock is currently owned by insiders.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Articles
- Five stocks we like better than HealthEquity
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
